IRIS
SVEGLIATI BARONI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.122
EU - Europa 4.981
AS - Asia 4.573
SA - Sud America 1.043
Continente sconosciuto - Info sul continente non disponibili 447
AF - Africa 257
OC - Oceania 8
Totale 23.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.727
SG - Singapore 1.458
IT - Italia 916
VN - Vietnam 911
RU - Federazione Russa 877
CN - Cina 789
BR - Brasile 775
UA - Ucraina 636
HK - Hong Kong 505
DE - Germania 488
IE - Irlanda 407
SE - Svezia 399
FR - Francia 324
GB - Regno Unito 245
FI - Finlandia 230
DK - Danimarca 202
TR - Turchia 181
CA - Canada 180
IN - India 127
BD - Bangladesh 121
KR - Corea 108
AR - Argentina 92
MX - Messico 75
MA - Marocco 61
CI - Costa d'Avorio 54
NL - Olanda 53
PL - Polonia 52
ZA - Sudafrica 52
IQ - Iraq 50
JP - Giappone 50
EC - Ecuador 47
ID - Indonesia 40
CO - Colombia 36
PK - Pakistan 33
UZ - Uzbekistan 29
CR - Costa Rica 28
AT - Austria 25
IL - Israele 24
BE - Belgio 23
CL - Cile 23
ES - Italia 23
VE - Venezuela 22
TT - Trinidad e Tobago 21
PY - Paraguay 20
HN - Honduras 16
SA - Arabia Saudita 16
GT - Guatemala 15
JO - Giordania 15
LT - Lituania 15
PH - Filippine 14
SV - El Salvador 14
DZ - Algeria 13
TN - Tunisia 13
EG - Egitto 12
KE - Kenya 12
NI - Nicaragua 12
AZ - Azerbaigian 11
CW - ???statistics.table.value.countryCode.CW??? 11
JM - Giamaica 11
MY - Malesia 11
UY - Uruguay 11
KZ - Kazakistan 10
SC - Seychelles 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
PR - Porto Rico 9
RS - Serbia 8
BO - Bolivia 7
PE - Perù 7
RO - Romania 7
AU - Australia 6
EU - Europa 6
KG - Kirghizistan 6
NP - Nepal 6
OM - Oman 6
TW - Taiwan 6
AL - Albania 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
AM - Armenia 4
BG - Bulgaria 4
CG - Congo 4
CZ - Repubblica Ceca 4
GR - Grecia 4
LU - Lussemburgo 4
NG - Nigeria 4
PT - Portogallo 4
SN - Senegal 4
BH - Bahrain 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KH - Cambogia 3
KW - Kuwait 3
LB - Libano 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
Totale 22.965
Salva come PNG Salva come JPEG
Città #
Ashburn 1.988
Singapore 884
Chandler 778
Jacksonville 655
San Jose 599
Fairfield 593
Hong Kong 495
Council Bluffs 481
Des Moines 460
Dallas 437
Dublin 404
Boardman 391
Ho Chi Minh City 326
New York 293
Wilmington 288
Woodbridge 269
Houston 255
Los Angeles 219
Seattle 212
Cambridge 191
Beijing 181
Hanoi 177
Centro 172
Munich 163
The Dalles 162
Lauterbourg 160
Princeton 155
Lawrence 152
San Mateo 145
Ann Arbor 142
Moscow 134
Helsinki 99
San Diego 94
São Paulo 92
Hefei 83
Santa Clara 81
Chicago 78
Milan 78
Guangzhou 71
Phoenix 67
London 63
Buffalo 61
Abidjan 54
Orem 53
Turin 51
Rome 46
Da Nang 39
Tokyo 39
Montreal 38
Chennai 36
Ancona 35
Washington 35
Atlanta 33
Denver 33
Haiphong 33
Wuhan 33
Brooklyn 31
Warsaw 31
Turku 30
Ottawa 29
Columbus 27
Johannesburg 26
Toronto 26
Tashkent 25
Mexico City 24
Poplar 24
Rio de Janeiro 24
Shanghai 24
Miano 23
Nuremberg 23
Salt Lake City 23
Boston 22
Frankfurt am Main 22
Norwalk 22
Stockholm 22
Baghdad 20
Pune 20
Redmond 20
San José 18
Amsterdam 17
Brussels 17
Curitiba 16
Irvington 16
Quito 16
Bologna 15
Dhaka 15
Marche 15
Elk Grove Village 14
Ankara 13
Belo Horizonte 13
Bogotá 13
Charlotte 13
Kraków 13
Miami 13
Mumbai 13
San Francisco 13
San Salvador 13
Amman 12
Can Tho 12
Fayetteville 12
Totale 14.236
Salva come PNG Salva come JPEG
Nome #
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 290
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 237
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 213
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature 212
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 208
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 201
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 191
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota 187
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 181
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 181
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 180
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 179
Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. 177
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 176
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 175
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 174
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 171
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to NASH 169
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 169
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 165
Immunological risk factors in biliary strictures after liver transplantation 163
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 162
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 160
Leptin enhances cholangiocarcinoma cell growth. 157
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 156
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 156
Mechanisms for increased risk of diabetes in chronic liver diseases 156
Cell proliferation following extrahepatic biliary obstruction. Evaluation by immunohistochemical methods. 152
Liver transplantation in patients with common variable immunodeficiency: a report of two cases 152
Gut-pancreas-liver axis as a target for treatment of nafld/nash 152
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 151
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. 151
Years of life that could be saved from prevention of hepatocellular carcinoma 150
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 149
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 149
From the metabolic syndrome to NAFLD or vice versa? 148
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 148
Hepatitis E in a region of Italy: An emerging autochthonous infection? 148
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 148
NERVE GROWTH FACTOR MODULATES THE PROLIFERATIVE CAPACITY OF THE INTRAHEPATIC BILIARY EPITHELIUM IN EXPERIMENTAL CHOLESTASIS. 145
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 144
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 144
Microwave ablation followed by cTACE in 5-cm HCC lesions: does a single-session approach affect liver function? 143
[L-sulpiride versus metoclopramide in functional dyspepsia: a randomized double-blind study] 143
Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. 143
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 143
Tocilizumab in COVID-19 interstitial pneumonia 142
Effect of cyanidin 3-O-beta-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress. 141
Liver transplantation in neurological Wilson's Disease: is there indication? A case report 141
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 140
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 139
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 139
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 138
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C 137
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 137
Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease 137
Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. 136
Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. 135
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 135
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 134
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 134
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease 134
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 134
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 134
Observer agreement in endoscopic assessment of ulcerative colitis. 133
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 133
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 133
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients 133
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 133
Lipotoxicity and the gut-liver axis in NASH pathogenesis 132
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 131
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease 131
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 129
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 129
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 129
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 129
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. 128
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 128
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis 128
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 128
Intracellular pathways mediating Na+/H+ exchange activation by platelet-derived growth factor in rat hepatic stellate cells. 127
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. 127
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area 127
BILE ACIDS INDUCE HEPATIC STELLATE CELL PROLIFERATION VIA ACTIVATION OF THE EPIDERMAL GROWTH FACTOR 126
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 124
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 124
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 123
A 360-degree overview of paediatric NAFLD: Recent insights 123
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. 123
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 123
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 122
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 122
Fibrogenesis in nonalcoholic steatohepatitis. 122
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 122
Wine: risk factors for liver disease and antifibrotic compounds. 122
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 121
Metabolic disorders across hepatocellular carcinoma in Italy 121
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 120
Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinoma 119
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 119
Totale 14.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022835 0 0 0 0 8 52 84 80 80 95 196 240
2022/20232.538 199 257 164 187 154 645 0 132 541 14 177 68
2023/20241.462 239 37 94 272 218 289 23 55 10 44 17 164
2024/20253.015 307 257 123 39 92 186 318 143 606 326 269 349
2025/20268.687 534 566 426 1.023 980 625 1.477 851 731 788 249 437
2026/20272.192 416 300 421 948 107 0 0 0 0 0 0 0
Totale 23.431